Strain Profile
Save

Lactobacillus crispatus

◐ Food-origin
Sequenced
Public genome assembly available

Lactobacillus crispatus is a lactic acid bacterium native to the human vaginal microbiota. Research has characterized the strain's genomic adaptation to host and body sites, and investigated its surface layer proteins and adhesion properties. Studies have examined the strain's role in vaginal dysbiosis, vulvovaginal candidiasis, and bacterial vaginosis in clinical and in vitro contexts. Comparative genomics have analyzed transport proteins and metabolomic properties across Lactobacillus species. The strain has been studied in animal models of vulvovaginal candidiasis.

Where it's been studied

Share of this strain's 1,448 body-system-tagged papers that concern each system. Research coverage, not measured effect.

+6 more systems

Symptoms in the research

Share of this strain's 585 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

+13 more symptoms

Strains of this species

3 strains of Lactobacillus crispatus in the index, with 63 linked papers between them.

Research

2245 papers reference this strain in the probiotic database.

Match confidence
ANIMAL
Anti-allergic effects of Lactobacillus crispatus KT-11 strain on ovalbumin-sensitized BALB/c mice
· Institutional Repositories DataBase (IRDB)
2026 OTHER
Vaginal Microbial Genome Collection (VMGC) MIDAS-compatible pangenome database
· Open MIND
2026 RCT
Vaginal microbiota impacts of a Lactobacillus crispatus live biotherapeutic and predictors of colonization in randomized controlled trial
· Cell Host & Microbe
2026 REVIEW
Unraveling the vaginal microbiota-based etiology of recurrent cystitis: the potential role of Lactobacillus vaginal suppositories
· Therapeutic Advances in Urology
2026 WGS
Women’s health is a team effort: probiogenomics supports the development of a multi-species vaginal probiotic
· Cellular and Molecular Life Sciences
2026 WGS
Exopolysaccharides of Lactobacillus crispatus mediate key balancing interactions with the vaginal mucosa
· bioRxiv (Cold Spring Harbor Laboratory)
2026 ANIMAL
Extracellular vesicles ameliorate intrauterine adhesion through Nrf2/GPX4-mediated ferroptosis suppression
· Journal of Advanced Research
2026 ANIMAL
Exploring the molecular crosstalk between the sex steroids drospirenone and ethinylestradiol with vaginal lactobacilli
· Frontiers in Microbiology
2026 IN_VITRO
Strain-dependent effects of the probiotic Lactobacillus crispatus on the physicochemical, technological, nutritional, and antimicrobial characteristics of fermented milk formulated for women
· Applied Food Research
2026 WGS
Exopolysaccharides of Lactobacillus crispatus mediate key balancing interactions with the vaginal mucosa
· npj Biofilms and Microbiomes
2026 IN_VITRO
Lactobacillus crispatus attenuates Escherichia coli-induced inflammation and migration of cervical cancer cells
· AMB Express
2026 IN_VITRO
Induction of Human β-Defensin-2 by Vaginal Lactobacillus crispatus Strains in Vaginal Epithelial Cells Correlates With Their Adhesion Abilities
· Open Forum Infectious Diseases
2026 WGS
Postbiotics originated from Lactobacillus crispatus NCU-31 improves vulvar lichen sclerosus: a randomized, double-blind controlled trial
· BMC Microbiology
2026 OBSERVATIONAL
A comparative analysis of urinary microbiome identifies putative probiotics
· bioRxiv (Cold Spring Harbor Laboratory)
2026 OTHER
Lactobacillus crispatus (Brygoo and Aladame 1953) Moore and Holdeman 1970 emend. Cato et al. 1983
· BacDive
2026 OTHER
Use of Eutoplac for the Prevention of Septic Complications in Post-Bariatric Patients Undergoing Body Contouring Surgery
· Journal of Surgery Research and Practice
2026 IN_VITRO
A microbiota–host axis mediates prostaglandin sensitivity: Lactobacillus crispatus as a biomarker and regulator of human labor induction
· npj Biofilms and Microbiomes
2026 IN_VITRO
Machine learning-based prediction of BV-relevant probiotic functional potential in vaginal-derived Lactobacillus crispatus strains
· BMC Microbiology
2026 IN_VITRO
Chicken-derived Lactobacillus strains alleviate Mycoplasma gallisepticum infection and improve growth performance in broilers
· Poultry Science
2026 ANIMAL
VIBRANT Trial primary and secondary outcomes processed data
· Zenodo (CERN European Organization for Nuclear Research)
Browse all 2,245 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    VIBRANT Trial primary and secondary outcomes processed data
    · Zenodo (CERN European Organization for Nuclear Research) · 2026
    Source →
  2. [2]
    Vaginal microbiota impacts of a Lactobacillus crispatus live biotherapeutic and predictors of colonization in randomized controlled trial
    · Cell Host & Microbe · 2026
    PMID 41903526 →
  3. [3]
    Postbiotics originated from Lactobacillus crispatus NCU-31 improves vulvar lichen sclerosus: a randomized, double-blind controlled trial
    · BMC Microbiology · 2026
    PMID 41566207 →
  4. [4]
    Unraveling the vaginal microbiota-based etiology of recurrent cystitis: the potential role of Lactobacillus vaginal suppositories
    · Therapeutic Advances in Urology · 2026
    PMID 42137495 →
  5. [5]
    Characterisation of vaginal Lactobacillus isolates from South African women towards the development of a biotherapeutic to optimise the vaginal microbiome
    · bioRxiv (Cold Spring Harbor Laboratory) · 2026
    PMID 41959050 →
  6. [6]
    Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial
    · The Lancet Microbe · 2025
    PMID 40194532 →
  7. [7]
    Randomized trial of multi-strain Lactobacillus crispatus vaginal live biotherapeutic products after antibiotic therapy for bacterial vaginosis: study protocol for VIBRANT (vaginal lIve biotherapeutic RANdomized trial)
    · Contemporary Clinical Trials Communications · 2025
    PMID 41050878 →
  8. [8]
    Impact of a multi-strain L. crispatus-based vaginal synbiotic on the vaginal microbiome: a randomized placebo-controlled trial
    · npj Biofilms and Microbiomes · 2025
    PMID 40783570 →
  9. [9]
    The Vaginal Microbiota, Human Papillomavirus, and Cervical Dysplasia—A Review
    · Medicina · 2025
    PMID 40428805 →
  10. [10]
    Cervicovaginal Microbiome: Physiology, Age-Related Changes, and Protective Role Against Human Papillomavirus Infection
    · Journal of Clinical Medicine · 2025
    PMID 40094958 →